These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. Martín-García C; Hinojosa M; Berges P; Camacho E; García-Rodriguez R; Alfaya T J Investig Allergol Clin Immunol; 2003; 13(1):20-5. PubMed ID: 12861847 [TBL] [Abstract][Full Text] [Related]
26. Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects. Pagani M; Bonadonna P; Dama A; Senna GE; Vescovi PP; Antico A Eur Ann Allergy Clin Immunol; 2010 Dec; 42(6):216-20. PubMed ID: 21287945 [TBL] [Abstract][Full Text] [Related]
27. Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis. Bressan E; Tonussi CR Inflamm Res; 2008 Dec; 57(12):586-92. PubMed ID: 19109739 [TBL] [Abstract][Full Text] [Related]
28. Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis. Setia S; Vaish V; Sanyal SN Mol Cell Biochem; 2012 Jul; 366(1-2):89-99. PubMed ID: 22411738 [TBL] [Abstract][Full Text] [Related]
29. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702 [TBL] [Abstract][Full Text] [Related]
31. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. El Miedany Y; Youssef S; Ahmed I; El Gaafary M Am J Gastroenterol; 2006 Feb; 101(2):311-7. PubMed ID: 16454836 [TBL] [Abstract][Full Text] [Related]
32. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325 [TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacology of etoricoxib. Capone ML; Tacconelli S; Patrignani P Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):269-82. PubMed ID: 16922642 [TBL] [Abstract][Full Text] [Related]
34. Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients. Bavbek S; Celik G; Pasaoglu G; Misirligil Z J Investig Allergol Clin Immunol; 2006; 16(1):57-62. PubMed ID: 16599250 [TBL] [Abstract][Full Text] [Related]
35. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Zacher J; Feldman D; Gerli R; Scott D; Hou SM; Uebelhart D; Rodger IW; Ozturk ZE; Curr Med Res Opin; 2003; 19(8):725-36. PubMed ID: 14687444 [TBL] [Abstract][Full Text] [Related]
36. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs. Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718 [TBL] [Abstract][Full Text] [Related]
37. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial. Steffens JP; Santos FA; Pilatti GL J Periodontol; 2011 Sep; 82(9):1238-44. PubMed ID: 21235334 [TBL] [Abstract][Full Text] [Related]
39. Benefits of the antioxidant and anti-inflammatory activity of etoricoxib in the prevention of ovarian ischemia/reperfusion injury induced experimentally in rats. Yapca OE; Turan MI; Yilmaz I; Salman S; Gulapoglu M; Suleyman H J Obstet Gynaecol Res; 2014 Jun; 40(6):1674-9. PubMed ID: 24888933 [TBL] [Abstract][Full Text] [Related]
40. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma. Micheletto C; Tognella S; Guerriero M; Dal Negro R Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]